Epstein Secrets

upgrades CMO, CS upgrades AXA, Kaufman reinstates EBAY (buy) Key Research: Cowen lowers estimates NVDA, Susquehanna raises target & estimates MRX, Jefferies upgrades WPRT (buy) Reporting Pre-Open: MON, MSM Reporting Post-Close: BBBY, APOG, BLVD, NAUH, OCNF, PBY, RELL, RT, SMSC, WDFC Economic Data: MBA

(set aside EFTA00435925 20% for conservation) U.K. manufacturing production unexpectedly stalled in Feb (unchanged from Jan vs estimate 40.6%) Marks & Spencer gains the most in six months as sales fall less than estimated (trading 45.47%) Novartis asks EU regulators to approve the Prexige pain pill that w

/LG FP, Equita upgrades LG FP ;••• Fidentiis upgrades BZU IM (buy), GS upgrades TRYG DC and VIG AV (buy) & cuts STL NO ••• HSBC downgrades VTBR LI, Jefferies upgrades O1BC GR and IMI LN (buy) & initiates AO LN (buy) • JPM initiates AO LN (ow), Kepler upgrades VIS SM and VOS GY/PSG SM/BDL SM (buy) • Norde

f Fraser Stake (Sunday Times) (trading -0.92%) • Leg Immobilien: €300 million convertible bond launch (pricing expected today) (trading -0.95%) • Marks & Spencer may miss sales targets laid out 2yrs ago says Sunday Times (trading -1.1%) • Germany Feb industry output expands more than forecast (+0.4% m/m vs e

downgrades CBOE (sell), W Blair upgrades ESI/DV/EDMC & downgrades CPLA/STRA, BofA initiates CLGX (buy) Key Research: Merriman upgrades KVHI (buy), Jefferies initiates SON (hold), Bofa downgrades HSBA.LN & initiates TMS (buy) Key Research: BMO downgrades LFT & DEER, CS resumes CYH & THC (op's), GS downgr

gn to "explore other opportunities") Valeant (VRX) agrees to buy AB Sanitas for 0314 million to add dermatology drugs in Eastern & Central Europe Marks & Spencer reports broadly inline with expectations but sounds cautious tone on outlook (trading -2.0%) U.K. budget deficit widens to $16.1B as tax receipts f